Filing Flows › BioScience Health Innovations (BHIC) › Q1 2026 › vs Q4 2025
BioScience Health Innovations (BHIC) Q1 2026 vs Q4 2025 (quarter over quarter)
BioScience Health Innovations's revenue fell $822K (-52%) from $1.6M in Q4 2025 to $751K in Q1 2026.
BioScience Health Innovations, Q1 2026: revenue $751K (-39% year over year), operating margin -30.6%, net loss $230K, operating cash flow −$552K. The chart draws each line against Q4 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q4 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $751K | $1.6M | −$822K | -52% |
| Net loss | $230K | $234K | −$4K | -2% |
| Costs & expenses | $981K | $1.8M | −$826K | -46% |
| Operating costs | $981K | $1.7M | −$749K | -43% |
| Cost of revenue | $265K | $1.0M | −$736K | -73% |
| SG&A | $626K | $656K | −$30K | -5% |
| Other operating costs | $40K | $72K | −$32K | -45% |
| Operating cash sources | $552K | $101K | $451K | +448% |
| Cash used in operations | $552K | $101K | $451K | +448% |
| Net loss absorbed | $230K | $234K | −$4K | -2% |
| Working capital & other | $322K | −$133K | $455K | — |
Questions
How much did BioScience Health Innovations's revenue grow quarter over quarter in Q1 2026?
BioScience Health Innovations's revenue fell $822K (-52%) from $1.6M in Q4 2025 to $751K in Q1 2026.